Scoop: Gilead ter­mi­nates ear­ly-stage FLT3 tri­al in sol­id tu­mors

Gilead chopped a Phase Ib dose es­ca­la­tion study in re­cent days, with an up­date to the fed­er­al tri­als data­base say­ing the pre­ma­ture ter­mi­na­tion fol­lowed an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER